Hana M. El Sahly

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 59 papers. Top paper: “Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial”.

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Science(2022)10.1126/science.abm3425

N/A

17.7DataRank · unranked

1207 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, David Benkeser, Weiping Deng +38 more

Homologous and Heterologous Covid-19 Booster Vaccinations

New England Journal of Medicine(2022)10.1056/nejmoa2116414

N/A

9.7DataRank · unranked

618 citations

Kirsten E. Lyke, Meagan E. Deming, Lisa A. Jackson, Angela R Branche, Hana M. El Sahly +33 more

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

New England Journal of Medicine(2021)10.1056/nejmoa2113017

N/A

8.3DataRank · unranked

662 citations

Lindsey R. Baden, Brandon Essink, Susanne Doblecki‐Lewis, Judith M. Martin, Evan J. Anderson +33 more

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

New England Journal of Medicine(2020)10.1056/nejmoa2031994

N/A

6.8DataRank · unranked

1924 citations

Thomas F. Patterson, Aneesh K. Mehta, Kay M Tomashek, Cameron R. Wolfe, Varduhi Ghazaryan +55 more

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100679

N/A

5.1DataRank · unranked

167 citations

Robert L. Atmar, Clara Domínguez Islas, Christine M. Posavad, Daniel Szydlo, Rahul Paul Chourdhury +64 more

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report

medRxiv(2021)10.1101/2021.10.10.21264827

N/A

5.1DataRank · unranked

98 citations

Kirsten E. Lyke, Meagan E. Deming, Lisa A. Jackson, Angela R Branche, Hana M. El Sahly +33 more

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00088-1

N/A

3.0DataRank · unranked

128 citations

Kay M Tomashek, Thomas F. Patterson, Carlos A. Gómez, Vincent C. Marconi, Mamta K. Jain +95 more

Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab111

N/A

2.3DataRank · unranked

21 citations

Jack T. Stapleton, Zuhair K. Ballas, Wendy Rasmussen, Thomas M. Kaufman, Tammy P Blevins +24 more

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration

Nature Communications(2023)10.1038/s41467-023-39292-w

N/A

1.9DataRank · unranked

44 citations

Meagan P. O’Brien, Jonathan Fintzi, Michael P. Fay, David C. Montefiori, Allyson Mateja +19 more

SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

medRxiv(2022)10.1101/2022.07.12.22277336

N/A

1.6DataRank · unranked

30 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +63 more

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine(2021)10.1056/nejmoa2035389

N/A

1.4DataRank · unranked

10600 citations

Hana M. El Sahly, Brandon Essink, Karen Kotloff, Sharon Frey, Rick Novak +32 more

Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial

Science Translational Medicine(2023)10.1126/scitranslmed.ade9078

N/A

1.3DataRank · unranked

48 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, Holly Janes, Weiping Deng +43 more

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature Medicine(2023)10.1038/s41591-023-02503-4

N/A

1.3DataRank · unranked

56 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +94 more

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants

npj Vaccines(2023)10.1038/s41541-023-00693-z

N/A

1.1DataRank · unranked

33 citations

Robert L. Atmar, Clara Domínguez Islas, Christine M. Posavad, Meagan E. Deming, Angela R Branche +69 more

Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00735-6

N/A

0.996DataRank · unranked

25 citations

Nadine Rouphael, Ruxana T. Sadikot, Maria C. Rodriguez‐Barradas, Micah T. McClain, Dana M Wilkins +32 more

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination

New England Journal of Medicine(2022)10.1056/nejmc2119912

N/A

0.897DataRank · unranked

394 citations

Nicole A. Doria‐Rose, Xiaoying Shen, Stephen D. Schmidt, Sijy O’Dell, Charlene McDanal +42 more

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac188

N/A

0.686DataRank · unranked

21 citations

Lindsey R. Baden, Brandon Essink, David C. Montefiori, Adrian McDermont, Richard Rupp +19 more

Topical Imiquimod Does Not Provide an Adjuvant Effect When Administered With Inactivated Influenza A/H5N1 Vaccine in Healthy Young Adults

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab206

N/A

0.608DataRank · unranked

11 citations

Robert L. Atmar, Eli A. Sendra, Ashley Wegel, Wendy A. Keitel, Hana M. El Sahly

Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18–64 Years: Results and Experience From a Randomized, Double-Blind Trial

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae559

N/A

0.585DataRank · unranked

11 citations

Jennifer A. Whitaker, Sarang K. Yoon, Karen Lutrick, S. K. Bhargava, C Perry Brown +27 more

Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-up Compared With Natural Infection

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac482

N/A

0.529DataRank · unranked

14 citations

Clemente Díaz, Francesco Nordio, Htay-Htay Han, Kelley J. Moss, Kelly Bohning +13 more

Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae689

N/A

0.444DataRank · unranked

8 citations

Xiaowei Wang, Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Peter B. Gilbert +13 more

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae198

N/A

0.439DataRank · unranked

13 citations

Kevin Rubenstein, Viviane Callier, Katy Shaw-Saliba, Adam Rupert, Robin Dewar +94 more

Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial

Nature Communications(2024)10.1038/s41467-024-52348-9

N/A

0.428DataRank · unranked

9 citations

Youyi Fong, Jonathan Fintzi, Eric Chun‐Pu Chu, Holly Janes, Avi Kenny +37 more

Risk of COVID-19 after natural infection or vaccination

EBioMedicine(2023)10.1016/j.ebiom.2023.104799

N/A

0.396DataRank · unranked

13 citations

Matthew B. Laurens, Ying Huang, Chenchen Yu, Thomas Martin, Carina A. Rodriguez +94 more

Identification of immunodominant T cell epitopes induced by natural Zika virus infection

Frontiers in Immunology(2023)10.3389/fimmu.2023.1247876

N/A

0.385DataRank · unranked

12 citations

Krystal A. Meza, Frances Terry, Chase G. Colbert, Azra Blazevic, Andrés H. Gutiérrez +14 more

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults

Clinical Infectious Diseases(2024)10.1093/cid/ciae173

N/A

0.384DataRank · unranked

11 citations

Robert L. Atmar, Emmanuel B. Walter, Sharon E. Frey, Jeffery L. Meier, Amy C Sherman +23 more

Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial

Research Square(2023)10.21203/rs.3.rs-2653179/v1

N/A

0.372DataRank · unranked

5 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +63 more

Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad276

N/A

0.312DataRank · unranked

7 citations

İnci Yıldırım, Sharon E. Frey, Patricia Winokur, Lisa A. Jackson, David I. Bernstein +26 more

Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials

Clinical Infectious Diseases(2022)10.1093/cid/ciac780

N/A

0.312DataRank · unranked

7 citations

Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Kashif Ali, Gary Berman +10 more

Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf176

N/A

0.284DataRank · unranked

4 citations

Kirsten E. Lyke, Christine M. Posavad, Meagan E. Deming, Rebecca C. Brady, David Dobrzynski +32 more

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial

Clinical Infectious Diseases(2024)10.1093/cid/ciae465

N/A

0.251DataRank · unranked

3 citations

Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen, Jing Wang +84 more

A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18–45 years of age

Vaccine(2025)10.1016/j.vaccine.2025.126991

N/A

0.226DataRank · unranked

3 citations

Emmanuel B. Walter, Michael J. Smith, James Campbell, Hana M. El Sahly, Jennifer A. Whitaker +20 more

Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad323

N/A

0.208DataRank · unranked

3 citations

Angela R Branche, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +80 more

Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination

Vaccine(2025)10.1016/j.vaccine.2025.127959

N/A

0.208DataRank · unranked

3 citations

Lindsey R. Baden, Hana M. El Sahly, Richard T. Davey, Paulina A. Rebolledo, David Diemert +17 more

1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad500.2470

N/A

0.208DataRank · unranked

3 citations

Xiaowei Wang, Peter B. Gilbert, Lindsey R. Baden, Hana M. El Sahly, Brandon Essink +10 more

Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens

Vaccine(2025)10.1016/j.vaccine.2024.126689

N/A

0.175DataRank · unranked

2 citations

Evan J. Anderson, Lisa A. Jackson, Kathleen M. Neuzil, Robert L. Atmar, David I. Bernstein +25 more

Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®

Vaccine(2025)10.1016/j.vaccine.2024.126702

N/A

0.173DataRank · unranked

2 citations

Rebecca C. Brady, Lisa A. Jackson, Paul Goepfert, Hana M. El Sahly, Robert L. Atmar +8 more

Cumulative Febrile, Respiratory, and Gastrointestinal Illness Among Infants in Rural Guatemala and Association With Neurodevelopmental and Growth Outcomes

The Pediatric Infectious Disease Journal(2023)10.1097/inf.0000000000004006

N/A

0.165DataRank · unranked

2 citations

Molly M. Lamb, Amy K. Connery, Alison M. Colbert, Diva M. Calvimontes, Desirée Bauer +14 more

A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf571

N/A

0.104DataRank · unranked

1 citations

Theresa Hegmann, Hana M. El Sahly, Evan J. Anderson, DMID 15-0038 Study Group, Nancy B. Wagner +14 more

Clinical Features and Treatment Outcomes of Pulmonary Mycobacterium avium-intracellulare Complex With and Without Coinfections

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac375

N/A

0DataRank · unranked

4 citations

Jack T. Stapleton, Arthur W. Baker, Nadine Rouphael, C. Buddy Creech, Hana M. El Sahly +17 more

Challenges and lessons learned from the rapid operationalization of a prospective cohort to study the natural history and neurodevelopmental outcomes of postnatal Zika virus infection among infants and children in rural Guatemala

PLoS neglected tropical diseases(2022)10.1371/journal.pntd.0010480

N/A

0DataRank · unranked

5 citations

Daniel Olson, Amy K. Connery, Diva M. Calvimontes, Guillermo A. Bolaños, Molly M. Lamb +20 more

Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials

medRxiv(2020)10.1101/2020.12.14.20248137

N/A

0DataRank · unranked

25 citations

Jonathan Fintzi, Michael P. Fay, Holly Janes, Lindsey R. Baden, Hana M. El Sahly +25 more

An evaluation of cytokine and cellular immune responses to heterologous prime-boost vaccination with influenza A/H7N7-A/H7N9 inactivated vaccine

Human Vaccines & Immunotherapeutics(2020)10.1080/21645515.2020.1750910

N/A

0DataRank · unranked

8 citations

George Makedonas, David B. Corry, Robert L. Atmar, Abbie R. Bellamy, Kaitlyn Cross +2 more

COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials

Clinical Infectious Diseases(2024)10.1093/cid/ciae192

N/A

0DataRank · unranked

6 citations

Jessica Tuan, Valeria D Cantos, Oladunni Adeyiga, Scott Mahoney, Ana M. Ortega‐Villa +25 more

Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients

Critical Care Explorations(2024)10.1097/cce.0000000000001159

N/A

0DataRank · unranked

3 citations

Omayma A. Kishk, Adnan Bhutta, Ginny E. Cummings, Hana M. El Sahly, Manpreet Virk +11 more

Postnatal Zika and Dengue Infection and their Effects on Neurodevelopment Among Children Living in Rural Guatemala

The Pediatric Infectious Disease Journal(2024)10.1097/inf.0000000000004646

N/A

0DataRank · unranked

3 citations

Amy Connery, Daniel Olson, Molly M. Lamb, Alejandra Paniagua-Ávila, Evan J. Anderson +21 more

Long-term safety and efficacy of COVE study open-label and booster phases

Research Square(2024)10.21203/rs.3.rs-3900939/v1

N/A

0DataRank · unranked

0 citations

Hana M. El Sahly, Brandon Essink, Dean Follmann, Gregory Hachigian, Cynthia Strout +19 more

Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial Disease

Clinical Infectious Diseases(2020)10.1093/cid/ciaa252

N/A

0DataRank · unranked

48 citations

Jack T. Stapleton, Nadine Rouphael, Buddy Creech, Jason E. Stout, Hana M. El Sahly +23 more

Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network

Clinical Infectious Diseases(2025)10.1093/cid/ciaf380

N/A

0DataRank · unranked

2 citations

Getahun Abate, Meagan E. Deming, Sarah L. George, Andrew Fleming, Sharon E. Frey +5 more

Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial

International Journal of Infectious Diseases(2023)10.1016/j.ijid.2023.09.012

N/A

0DataRank · unranked

14 citations

Xiaoying Shen, Lindsay N. Carpp, David Benkeser, Dean Follmann, Holly Janes +8 more

A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure-Proximal Design but Requires Far Fewer Blood Samples

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf572

N/A

0DataRank · unranked

0 citations

Lauren Dang, Eric Chun‐Pu Chu, Jonathan Fintzi, Holly Janes, Peter B. Gilbert +13 more

Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial

Viruses(2023)10.3390/v15102029

N/A

0DataRank · unranked

17 citations

Nima S. Hejazi, Bryan S. Blette, Lindsay N. Carpp, David Benkeser, David C. Montefiori +38 more

Cumulative Febrile, Respiratory, and Diarrheal Illness among Infants in Rural Guatemala and their Association with Neurodevelopmental and Growth Outcomes

medRxiv(2022)10.1101/2022.09.02.22279419

N/A

0DataRank · unranked

0 citations

Molly M. Lamb, Amy K. Connery, Alison M. Colbert, Mirella Calvimontes, Desirée Bauer +14 more

Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial

medRxiv(2022)10.1101/2022.04.18.22271936

N/A

0DataRank · unranked

14 citations

Holly Janes, Olive D. Buhule, Honghong Zhou, Bethany Girard, Kristen Marks +8 more

Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad069

N/A

0DataRank · unranked

10 citations

Holly Janes, Eric Chun‐Pu Chu, Lakshmi Jayashankar, Christos J. Petropoulos, Leonid Serebryannyy +19 more

Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad290

N/A

0DataRank · unranked

2 citations

Noreen A. Hynes, Corri B. Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg +37 more

Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac219

N/A

0DataRank · unranked

2 citations

Tyler Bonnett, Pablo Tebas, Vincent C. Marconi, Corri B. Levine, Hana M. El Sahly +14 more

A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated

UNC Libraries(2023)10.17615/wz35-3h79

N/A

0DataRank · unranked

0 citations

Michael P. Fay, Dean Follmann, Deborah Donnell, James G. Kublin, Myron S. Cohen +24 more

Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.15984

N/A

0DataRank · unranked

4 citations

Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Kathleen M. Neuzil, Lawrence Corey +7 more